Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Aifukang** is an oral multi-herb traditional Chinese medicine capsule preparation studied in China as an adjunctive treatment for HIV infection and acquired immunodeficiency syndrome. Clinical publications report improvements in patient-reported symptoms, body weight, and immunologic measures, while evidence for a direct effect on HIV viral load is inconsistent or limited. Its molecular composition, direct antiviral targets, originator, manufacturer, and regulatory marketing status were not established in the located public sources. ([ir.pku.edu.cn](https://ir.pku.edu.cn/handle/20.500.11897/231290))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aifukang.